CS244448B2 - Method of aminopyrimidine derivatives production - Google Patents

Method of aminopyrimidine derivatives production Download PDF

Info

Publication number
CS244448B2
CS244448B2 CS845810A CS581084A CS244448B2 CS 244448 B2 CS244448 B2 CS 244448B2 CS 845810 A CS845810 A CS 845810A CS 581084 A CS581084 A CS 581084A CS 244448 B2 CS244448 B2 CS 244448B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
group
compound
compounds
residue
Prior art date
Application number
CS845810A
Other languages
Czech (cs)
English (en)
Other versions
CS581084A2 (en
Inventor
Thomas H Brown
David Tuddenham
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of CS581084A2 publication Critical patent/CS581084A2/cs
Publication of CS244448B2 publication Critical patent/CS244448B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CS845810A 1983-07-29 1984-07-27 Method of aminopyrimidine derivatives production CS244448B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320505A GB8320505D0 (en) 1983-07-29 1983-07-29 Chemical compounds

Publications (2)

Publication Number Publication Date
CS581084A2 CS581084A2 (en) 1985-08-15
CS244448B2 true CS244448B2 (en) 1986-07-17

Family

ID=10546495

Family Applications (1)

Application Number Title Priority Date Filing Date
CS845810A CS244448B2 (en) 1983-07-29 1984-07-27 Method of aminopyrimidine derivatives production

Country Status (21)

Country Link
EP (1) EP0134096B1 (de)
JP (1) JPS6051179A (de)
KR (1) KR850001174A (de)
AT (1) ATE40552T1 (de)
AU (1) AU564650B2 (de)
CA (1) CA1261831A (de)
CS (1) CS244448B2 (de)
DD (1) DD216933A5 (de)
DE (1) DE3476541D1 (de)
DK (1) DK368284A (de)
ES (1) ES8600254A1 (de)
FI (1) FI842976A7 (de)
GB (1) GB8320505D0 (de)
GR (1) GR82226B (de)
HU (1) HUT34743A (de)
IL (1) IL72491A0 (de)
JO (1) JO1327B1 (de)
NO (1) NO843043L (de)
PT (1) PT78977B (de)
ZA (1) ZA845820B (de)
ZW (1) ZW11584A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772704A (en) * 1983-09-21 1988-09-20 Bristol-Myers Company 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
JP2007531753A (ja) 2004-03-31 2007-11-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 非イミダゾール系複素環式化合物
MX339668B (es) 2006-05-30 2016-06-02 Janssen Pharmaceutica N V * Compuestos de piridil amida sustituidos como moduladores del receptor h3 de la histamina.
CN105712977B (zh) 2007-11-20 2021-06-29 詹森药业有限公司 作为组胺h3受体调节剂的环烷基氧基吡啶化合物和杂环烷基氧基吡啶化合物
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (de) * 1978-02-13 1983-03-05 Smith Kline French Lab
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
IL72491A0 (en) 1984-11-30
CS581084A2 (en) 1985-08-15
GB8320505D0 (en) 1983-09-01
EP0134096A3 (en) 1985-12-18
JO1327B1 (en) 1986-11-30
FI842976L (fi) 1985-01-30
EP0134096A2 (de) 1985-03-13
AU564650B2 (en) 1987-08-20
KR850001174A (ko) 1985-03-16
GR82226B (de) 1984-12-13
FI842976A0 (fi) 1984-07-26
ZW11584A1 (en) 1985-04-17
DE3476541D1 (de) 1989-03-09
ATE40552T1 (de) 1989-02-15
PT78977B (en) 1986-06-05
AU3099184A (en) 1985-01-31
FI842976A7 (fi) 1985-01-30
DK368284D0 (da) 1984-07-27
DD216933A5 (de) 1985-01-02
NO843043L (no) 1985-01-30
PT78977A (en) 1984-08-01
HUT34743A (en) 1985-04-28
DK368284A (da) 1985-01-30
ES534620A0 (es) 1985-09-16
ES8600254A1 (es) 1985-09-16
JPS6051179A (ja) 1985-03-22
EP0134096B1 (de) 1989-02-01
CA1261831A (en) 1989-09-26
ZA845820B (en) 1985-06-26

Similar Documents

Publication Publication Date Title
DE69427289T2 (de) Naphtalinderivate
US4338317A (en) Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4746664A (en) Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
CH662562A5 (de) 1,2,4-triazol-3-on-verbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel.
JPH0559118B2 (de)
DK162519B (da) Dihydropyridazinonderivater og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende forbindelserne
PL136217B1 (en) Method of obtaining novel derivatives of 4-amino-6,7-dimetoxy-2-piprazinoquinazoline
DE19512639A1 (de) Benzonitrile und -fluoride
EP1002796A2 (de) Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE3827727A1 (de) Anellierte tetrahydropyridinessigsaeurederivate, verfahren zu deren herstellung und verwendung solcher verbindungen zur kardioprotektion
DE69116788T2 (de) 4-substituierte Dihydropyrido [4,3-d] pyrimidine als Analgetika und entzündungshemmende Mittel zur topischen Anwendung bei der Behandlung von Hauterkrankungen
EP0596891B1 (de) Aminoalkylsubstituierte 2-amino-5-mercaptothiadiazole, ihre herstellung und verwendung
DK156722B (da) Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater
JPS59216877A (ja) 置換フエニル−2−(1h)−ピリミジノン
JPH0550515B2 (de)
HU191126B (en) Process for producing new n-imino-pyridinium-betaine derivatives and pharmaceutical compositions containing them as active agents
CA1155842A (en) Compounds
EP0134096B1 (de) Aminopyrimidinon-Derivate als Histamin-H2-Antagonisten
EP0589908B1 (de) Aminoalkylsubstituierte thiazolin-2-one, ihre herstellung und verwendung
US5418235A (en) Aminoalkyl-substituted 5-mercaptothiazoles, the preparation and use thereof
US4386091A (en) 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
EP0696289B1 (de) Benzo[f]chinoxalindionderivative, deren herstellung und verwendung in arzneimitteln
IE48442B1 (en) Imidazolylethyl ether derivatives of pyrazolo(3,4-b)pyridine-5-methanols
EP0592453B1 (de) Aminoalkylsubstituierte 2-amino-1,3,4-thiadiazole, ihre herstellung und verwendung
KR0148365B1 (ko) 4,5,5a,6-테트라하이드로-3H-이소옥사졸로[5,4,3-kl]아크리딘 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물